2 results
Approved WMOCompleted
Our main objective is to evaluate and compare appliance of EndobonĀ® Xenograft Granules (Biomet 3i) with an established bovine derived bone mineral for regeneration of intra-bony peri-implantitis defects.
Approved WMOWill not start
To compare the progression-free survival (PFS) in subjects with pancreatic islet cell tumors treated with sunitinib at a starting dose of 37.5 mg daily (continuous dosing) with those treated with placebo.